Study of Netarsudil Ophthalmic Solution in Japanese/Japanese-American Subjects With Open-angle Glaucoma or Ocular Hypertension
Clinical trial NCT03310580 · COMPLETED
Trial details
- NCT number
- NCT03310580
- Sponsor
- Aerie Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-15
- Primary completion
- 2018-10-25
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.